New asthma shot aims to tame severe attacks

NCT ID NCT07342803

Recruiting now Disease control Sponsor: Longbio Pharma Source: ClinicalTrials.gov ↗

Summary

This study is testing an investigational injection called LP-003 for adults with moderate to severe allergic asthma that isn't fully controlled with standard inhalers. The goal is to see if the injection can reduce the number of asthma flare-ups, improve breathing, and enhance quality of life compared to a placebo or an existing drug. About 200 participants will receive injections and be monitored for safety and effectiveness over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ruijin Hospital
RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ALLERGIC ASTHMA